These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10379014)

  • 21. The U.S. Environmental Protection Agency's risk assessment guidelines.
    Jarabek AM; Farland WH
    Toxicol Ind Health; 1990 Oct; 6(5):199-216. PubMed ID: 2274984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The U.S. Environmental Protection Agency's examination of its risk assessment principles and practices: a brief perspective from the regulated community.
    Stahl RG; Guiseppi-Elie A; Bingman TS
    Integr Environ Assess Manag; 2005 Jan; 1(1):86-92. PubMed ID: 16637153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drawing the battle lines: tracing the "Science War" in the construction of the chloroform and human health risks debate.
    Driedger SM; Eyles J
    Environ Manage; 2003 Apr; 31(4):476-88. PubMed ID: 12677294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is ingested inorganic arsenic a "threshold" carcinogen?
    Abernathy CO; Chappell WR; Meek ME; Gibb H; Guo HR
    Fundam Appl Toxicol; 1996 Feb; 29(2):168-75. PubMed ID: 8742312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A discussion of the U.S. EPA methodology for determining Water Quality Standards (WQS).
    Burmaster DE; von Stackelberg KE
    Qual Assur; 1992 Jun; 1(3):192-206. PubMed ID: 1344674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mode of action studies in extrapolating to human risks in toxicology.
    Lock EA; Smith LL
    Toxicol Lett; 2003 Apr; 140-141():317-22. PubMed ID: 12676480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topics in cancer risk assessment.
    Olin SS; Neumann DA; Foran JA; Scarano GJ
    Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):117-26. PubMed ID: 9114281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking water.
    Clewell HJ; Gentry PR; Hack CE; Greene T; Clewell RA
    Regul Toxicol Pharmacol; 2019 Apr; 103():237-252. PubMed ID: 30707931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinogen risk assessment in the U.S. Environmental Protection Agency.
    Albert RE
    Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The U.S. Environmental Protection Agency's risk assessment guidelines: current status and future directions.
    Farland WH
    Toxicol Ind Health; 1991; 7(5-6):313-7. PubMed ID: 1780873
    [No Abstract]   [Full Text] [Related]  

  • 34. No evidence of dioxin cancer threshold.
    Mackie D; Liu J; Loh YS; Thomas V
    Environ Health Perspect; 2003 Jul; 111(9):1145-7. PubMed ID: 12842764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on EPA carcinogen risk assessment guidelines.
    Moolenaar RJ
    Regul Toxicol Pharmacol; 1989 Jun; 9(3):230-5. PubMed ID: 2756170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A framework for human relevance analysis of information on carcinogenic modes of action.
    Meek ME; Bucher JR; Cohen SM; Dellarco V; Hill RN; Lehman-McKeeman LD; Longfellow DG; Pastoor T; Seed J; Patton DE
    Crit Rev Toxicol; 2003; 33(6):591-653. PubMed ID: 14727733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Default assumptions in carcinogen risk assessment used by regulatory agencies.
    Moolenaar RJ
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 2):S135-41. PubMed ID: 7724845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenic effects of benzene--a status update and research needs to improve risk assessments: US EPA perspective. Environmental Protection Agency.
    Sonawane B; Bayliss D; Valcovic L; Chen C; Rodan B; Farland W
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):471-2. PubMed ID: 11086954
    [No Abstract]   [Full Text] [Related]  

  • 39. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New risk assessment initiatives in EPA.
    Anderson EL; Ehrlich AM
    Toxicol Ind Health; 1985 Dec; 1(4):7-22. PubMed ID: 3843513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.